Arcus Biosciences (RCUS) PT Raised to 'Street High' $70 at Truist Securities
Tweet Send to a Friend
Truist Securities analyst Robyn Karnauskas raised the price target on Arcus Biosciences (NYSE: RCUS) to a "Street HIgh" $70.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
